Related Experiment Videos
Oncogenes and oncoproteins as tumor markers
1Department of Family & Community Medicine, University of Arizona, Tucson.
Summary
New cancer markers derived from specific genes offer hope for early detection and personalized treatment. Analyzing oncogenes and tumor suppressor genes can predict tumor behavior and guide therapy effectively.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Genetics
Background:
- Current cancer management faces challenges due to the absence of specific markers for early detection, prognosis, and predicting tumor behavior.
- The discovery of malignancy-associated genes presents a potential solution to these diagnostic and prognostic limitations.
Purpose of the Study:
- To explore the potential of oncogenes and tumor suppressor genes as novel tumor markers.
- To investigate how analyzing altered gene expression can improve cancer diagnosis, prognosis, and treatment selection.
Main Methods:
- Reviewing current research on the role of specific genes and their products in malignancy.
- Discussing the clinical applications of analyzing altered oncogene and tumor suppressor gene expression in neoplastic tissues.
Main Results:
- Altered expression of oncogenes and tumor suppressor genes can serve as diagnostic and prognostic markers.
- Gene expression analysis shows potential in predicting tumor behavior and response to therapies.
Conclusions:
- Detailed analysis of gene expression, particularly oncogenes and tumor suppressor genes, holds significant promise for advancing cancer care.
- These genetic markers can lead to more precise characterization of individual tumors, improving patient outcomes.